Manufacture

Biologic medicines present unique challenges for pharmacovigilance. And with biosimilars hitting the market, life just got more complicated.

Can a new generation of chromatography techniques and technologies get things moving again?

Researchers estimate the cost of drug development at over $1 billion, while others say it’s less than $100 million. Who’s right?

The launch of the world’s first biosimilar monoclonal antibody was a big step forward from a regulatory and scientific standpoint.

The Galactic Grant Competition encourages companies to use the International Space Station for pharmaceutical R&D

A business simulation video game called Big Pharma is being made by a UK game studio called Twice Circled.

It is clear that terminal sterilization is the gold standard for sterile drug manufacture, so why are companies so reluctant to pursue it?

Many drug developers are going ‘full steam ahead’ with personalized medicine strategies.

The rise of drug resistance has left us facing a future with few effective antibiotics. Do the next-generation antibiotics in the pipeline offer hope?

Sitting Down With… Nick Haggar, Head of Western Europe, Middle East & Africa, Sandoz, and President of the European Generic Medicines Association (EGA).